长城医药科技六个月持有混合C(011674)资产负债表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
65,279,520.11 |
| 结算备付金 |
979,827.41 |
894,835.87 |
3,096,610.05 |
1,379,348.88 |
| 存出保证金 |
183,441.83 |
204,454.68 |
230,948.45 |
270,055.70 |
| 交易性金融资产 |
330,029,654.12 |
353,988,353.62 |
465,726,727.05 |
522,426,427.49 |
| 其中：股票投资 |
330,029,654.12 |
353,988,353.62 |
465,366,700.22 |
522,426,427.49 |
| 债券投资 |
- |
- |
360,026.83 |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
1,056,615.04 |
3,083,056.18 |
1,078,772.79 |
2,265,967.01 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
5,332.42 |
- |
- |
| 应收申购款 |
26,988.24 |
8,184.62 |
11,470.17 |
15,394.44 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
392,546,073.82 |
403,792,048.79 |
536,841,206.13 |
591,636,713.63 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
8,463,947.22 |
2,896,483.46 |
3,812,391.06 |
2,608,402.81 |
| 应付赎回款 |
528,395.57 |
641,643.57 |
308,580.94 |
677,647.49 |
| 应付管理人报酬 |
412,133.94 |
413,039.32 |
548,764.40 |
735,907.33 |
| 应付托管费 |
68,688.99 |
68,839.91 |
91,460.74 |
122,651.21 |
| 应付销售服务费 |
13,723.98 |
13,716.61 |
18,574.75 |
20,001.65 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
0.96 |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
507,071.68 |
643,850.94 |
1,242,502.23 |
1,056,363.69 |
| 负债合计 |
9,993,961.38 |
4,677,573.81 |
6,022,275.08 |
5,220,974.18 |
| 所有者权益 |
| 实收基金 |
704,338,124.73 |
757,858,930.14 |
804,157,392.13 |
857,946,591.71 |
| 未分配利润 |
-321,786,012.29 |
-358,744,455.16 |
-273,338,461.08 |
-271,530,852.26 |
| 所有者权益合计 |
382,552,112.44 |
399,114,474.98 |
530,818,931.05 |
586,415,739.45 |
| 负债及所有者权益总计 |
392,546,073.82 |
403,792,048.79 |
536,841,206.13 |
591,636,713.63 |
微信公众号
证券之星APP
基本资料
